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Introduction
Infective endocarditis (IE) is a rare infection which mostly
afflicts patients with a predisposing cardiac condition. The
characteristics of patients presenting with IE have
changed with time even in developing countries.1 A trend
towards an increasing number of infections in
degenerated and prosthetic valve disease as opposed to
rheumatic and congenital heart disease has been
observed. The incidence of nosocomial and procedure-
related endocarditis also appears to be on the rise.2
Despite improvements in diagnostic modalities and
clearly defined diagnostic criteria and management
guidelines, case morbidity and fatality remain high. This is
especially true for hospitalised patients with IE where
reported mortality is as high as 20-25%.3,4
Many studies have attempted to delineate parameters on
the basis of which we can identify those at highest risk of
mortality.3 The results from these studies are fairly
heterogenous, and no predictive model has been
developed to date.
The current study was planned to evaluate the clinical
characteristics and predictors of in-hospital mortality in IE
patients at a tertiary care centre in Pakistan.
Patients and Methods
The cross-sectional study was conducted at the Aga Khan
University Hospital, Karachi, from January 1, 2002, to
December 31, 2006, and comprised 84 consecutive in-
hospital IE patients enrolled through convenience
sampling. 
Only those patients in whom verification of the diagnosis
according to the Modified Duke criterion was possible
were included. Informed consent was obtained from all
patients. At the time the study was conducted, chart
reviews did not require clearance from the institutional
ethics review committee.
All patient information pertained to events that occurred
during hospitalisation. Data was primarily collected
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through chart review and a questionnaire was filled.
Missing information, if any, was collected by the principal
researcher through analysis of laboratory results and
clinical assessment of the patient. This information was
verified by the admitting physician. Information on
demographic and laboratory parameters and pre-
specified in-hospital outcomes was obtained. 
These included details regarding the history and physical
examination along with relevant laboratory tests and
echocardiography. Clinical outcomes including death and
significant morbidity such as congestive cardiac failure,
peripheral embolisation and neurological complications
were also documented.
SPSS 19 was used for data analysis. Continuous variables
with normal and non-normal distributions were reported
as mean ± standard deviation (SD) and median [inter-
quartile range (IQR)], respectively, while frequency and
percentage were calculated for qualitative variables.
Student's t test was used to compare quantitative
variables and Chi square and Fisher's exact test for
categorical variables.
Primary outcome of in-hospital mortality versus discharge
was dichotomised. Clinical characteristics associated with
mortality on univariate analysis were age, neurological
complications, congestive cardiac failure, arrhythmias,
coexisting infection, serum albumin and serum creatinine.
In univariate analysis p<0.25 was used as the level of
significance in order not to exclude important variables
from the model. Multivariable models were then
constructed, including variables that showed an effect in
the prediction of mortality in the univariate analysis. Odds
Ratios (OR) and their 95% Confidence Intervals (CI) were
estimated using logistic regression analyses, with
mortality as an outcome. All p values were 2-sided and
p<0.05 was considered statistically significant.
Results
Of the 84 patients in the study 53(63%) patients were
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Table-1: Comparison of clinical characteristics of study population by outcome.
Total In-hospital mortality group Alive at discharge group P value
n=27 n=57
Age (years) 42 ± 17 44 ± 17 41 ± 18 0.44
Male 53(63) 17(63) 36(63) 0.99
Female 31(37) 10(37) 21(37) >0.999
Clinical Presentation
Fever 82(98) 27(100) 55(96) 0.99
Murmur 74(88) 25(93) 49(86) 0.48
Splenomegaly 17(20) 4(15) 13(23) 0.56
Valve involved type and site
Native valve IE 72(86) 23 (85) 49(86) 1.0
Prosthetic valve IE 6(7) 3(11) 3(5) 0.38
Isolated mitral valve 43(51) 15(56) 18(31) 0.64
Multiple valves 13(15) 7(26) 6(10) 0.10
Isolated aortic valve 18(21) 4(15) 14(25) 0.39
Microorganism isolated
MRSA 12 (14) 5 (18) 7 (12) 0.51
Strep Viridans 10(12) 2(7) 8(14) 0.48
Culture negative 28 (33) 8 (30) 20 (35) 0.80
Complications & treatment 
Renal Failure 38(45) 17(63) 21(37) 0.03
Vegetations on echo 69(82) 23(85) 46(81) 0.76
Arrhythmias 15(18) 11(41) 4(7) <0.001
Peripheral embolism 16(19) 11(41) 5(9) 0.001
Coexisting Infection 40(48) 19(70) 21(37) 0.005
Congestive heart failure 18(21) 12(44) 6(11) 0.001
Neurological complications 28(33) 18(67) 10(17) <0.001
Presence of haemolysis 11(13) 4(15) 7(12) 0.74
Valve abscess 6(7) 3(11) 3(4) 0.38
Surgical intervention 17(20) 3(11) 14(25) 0.24
IE: Infective Endocarditis.
MRSA: Methicillin-Resistant Staphylococcus Aureus.
male and 31(37%) female, with an overall mean age of
42±17 years. Predisposing condition in 34(41%)
patients was prior rheumatic heart disease. Other
predisposing conditions included congenital heart
disease in 10 (12%), recent central venous catheter
placement 9(11%), recent intravenous (IV) antibiotics
treatment 8(10%), prosthetic valve 6(7%) and IV drug
use in 4(5%) patients. In 8(9%) patients no risk factors
could be identified. 
The most commonly affected valve was mitral in 43 (51%),
followed by multiple valve involvement in 13(15%), and
isolated aortic valve involvement in 18(21%).
Mean duration of symptoms at the time of hospital
presentation was 28±26 days, ranging from 2 to 90 days
with a median of 15 days (IQR: 8, 45). Fever was present
in all patients. Besides, 74(88%) patients had a murmur
on auscultation, either on presentation or during
subsequent examination. Splenomegaly was observed
in 17(20%) patients. Classical signs of vasculitis or
immunological phenomena associated with sub-acute
IE were observed in only a few patients: Roth spots in
4(5%) patients, Osler nodes in 3(3.5%) and Janeway
lesions in 9(10%).
Blood cultures were positive in 56 (66.6%) patients. The
most commonly isolated organism was methicillin-
resistant staphylococcus aureus in 12(14.3%) patients,
followed by streptococcus viridians and enterococci in
10(12%) each (Table-1). 
Vegetations were present in 69(82%) patients on
echocardiography and valve abscess in 6(7%). Besides,
52(62%) patients were diagnosed with IE on transthoracic
echo only, 26(31%) required additional transesophageal
study, while transesophageal echo (TEE) was the initial
imaging modality in 6(7%) patients. 
All patients received antibiotic therapy. Mean
antibiotic duration was noted during in-hospital stay
only, and was found to be 3.74±1.8 weeks. The mean
antibiotic duration in those patients who underwent
surgery was 4.17±1.5 weeks. Five (5.9%) patients
received one antibiotic, while 27(32%) received three
antibiotics. The remaining 52(62%) patients received
two antibiotics.
Seventeen (20%) patients underwent surgical
intervention. Surgical indications included embolic
complications (including stroke) in 5(6%) patients,
congestive heart failure in 4(5%), large vegetations in
4(5%) and perivalvular abcess in 1(1.1%). The remaining
3(3.5%) patients required surgery for persistent
bacteraemia.
Overall in-hospital mortality was 27(32.1%) at the end of
the 5-year study period. In-hospital mortality occurred
within a range of 1 to 53 days, with a median of 14 (mean:
17±14 days) from the time of hospitalisation. 
Eighteen (21%) patients developed congestive cardiac
failure, 15(18%) developed arrhythmias (predominantly
complete heart block) and valve abscess formation was
observed in 6(7%). Besides, 28(33%) patients developed
neurological complications, while 16(19%) developed
peripheral embolism. Renal failure was present in
46(54%) patients with an observed median serum
creatinine value of 2.3 and median 1.2 (IQR: 0.9, 2.5)
mg/dl.
Univariate analysis found the following factors to be
significant: age >50 (p <0.007), arrhythmias (p <0.017),
neurological complications (p <0.001), congestive cardiac
failure (p <0.001), renal failure (p <0.027), other coexisting
infection (p <0.005) and serum creatinine level >1.4 (p
<0.04) (Table-2).
The final multivariate model to predict mortality
consisted of the presence of neurological complications
(p <0.001) OR 7.26, CI (2.27-23.18), congestive cardiac
heart failure (p <0.023) OR 5.39 CI (1.26-23.04), and
arrhythmias (p <0.034) OR 4.21, CI (1.11-15.88).
Discussion
A review of initial South Asian literature describing the
demographics and outcomes of hospitalised IE patients
revealed a spectrum similar to that of the West of about 40
years previously.5
Patients were younger, had rheumatic valvular heart
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Table-2: Univariate and multivariate analysis.
Univariate
Variable OR (95% CI) P-value
Age 2.33(0.912-5.96) p=0.07
Neurological complications 9.4(3.28-26.9) p=<0.005
Congestive cardiac failure 6.8(2.18-21.18) p=0.001
Arrhythmias 9.10(2.54-32.5) p=0.001
Coexisting Infection 4.071(1.51-10.91) p=0.005
Serum albumin level 0.170(0.17-1.67) p=0.13
Serum creatinine level 2.976(1.03-8.58) p=0.04
Multivariate
Neurological complications 7.26(2.27-23.18) p=0.001




disease or congenital heart disease as a predisposing
condition, predominantly grew streptococci or were
culture-negative and were less likely to undergo
surgery.
Two studies5,6 had found a mean age of 27.6 and 29
years respectively. In contrast, two others4,7 found it to
be 58 and 57 years. A study from Turkey1 revealed a
mean age of 45±19 years, which is similar to our
findings. However, one study8 reported a mean age of
23±8.9 years. This may reflect differences in populations
who present at various tertiary care hospitals. However,
the same authors found a higher proportion of
staphylococcal endocarditis. This may imply that some
aspects of the clinical spectrum in developing countries
may be changing and may now more closely reflect
Western trends.
Regional studies showed a higher frequency of
endocarditis in men.9 However, female gender has been
found to be associated with a worse prognosis, though
this has not been unequivocally proven. In our study,
gender was not a significant predictor of mortality.
Rheumatic heart disease was the most prevalent risk
factor in our cohort, which has remained a consistent
feature in most studies published from the region.5,6,8
The majority of our patients had native valve endocarditis.
Congenital heart disease was present in 12 per cent
patients of which the most common condition was a
ventricular septal defect. Seven per cent patients
presented with prosthetic valve endocarditis (PVE). A
study10 in 1981 reported that 13% of its subjects had
PVE6. Since then the incidence has been steadily
increasing. A review11 of 4106 patients admitted to the
ICU found 21% to have PVE. And two other studies3,7
found that 32% and 26% of their study population had
PVE respectively.
In 8 study patients, no predisposing factor was identified
except the administration of IV antibiotics for an
unrelated infection prior to the development of
endocarditis. An increasing trend of invasive medical
procedures has been associated with the risk of
nosocomial endocarditis.12 It is possible that these
patients developed endocarditis due to haematogenous
introduction of pathogens through this route. 
In the Euro heart study,7 and a 15-year review,13 the most
commonly affected valve was aortic. However, local and
regional studies1,5,8 reported predominantly mitral valve
endocarditis, either alone or in combination with
another valve.
Blood cultures were positive in 67% of our patients. This
was in contrast to earlier findings in Pakistan9 that had
lower yield on blood cultures and had postulated prior
antibiotic administration as a reason. Another study6
had reported 52% culture-positive endocarditis. The
most recent local data9 found 53.3% culture yield.
Western literature reports higher microbiological yield.
An American Heart Association (AHA) consensus
statement14 on the subject reports up to 20% culture
negativity. However, the same authors submitted that
most series reported up to 95% culture positivity. Lower
yields in our part of the world likely reflect the increased
frequency of prior antibiotic use as well as unavailability
or limited use of culture media and methods for
fastidious organisms as well as immunological methods
for microbiological identification. The AHA document
emphasises that these conditions may reduce recovery
rate of bacteria by 35-40%.14
Altogether, 62 per cent of our patients were reliably
diagnosed with endocarditis on a transthoracic
echocardiogram. The remaining 38% underwent both
transthoracic and transesophageal echo, or TEE alone. In
our cohort, only 6(7%) patients had PVE. At our institute,
the use of echo in patients with endocarditis is in
accordance with international guidelines. The AHA
consensus statement14 advocates that TEE should be
utilised early if there is high initial patient risk, moderate
or high suspicion of endocarditis or poor
echocardiographic windows. 
The most commonly isolated pathogen in our study was
methicillin-resistant staphylococcus aureus. Since this was
a hospital-based study, there was a higher proportion of
patients who had undergone invasive procedures such as
central venous catheter placement. The microbiology is
probably reflective of this trend. This trend has also been
borne out in similar hospital-based studies15,16 The
presence of staphylococcus on culture was found to be a
predictor of in-house mortality in a cohort by several
authors.4,17
IE poses many challenges because myriad complications
may occur, which may impact morbidity and mortality
from the disease. Neurological complications occurred in
about a third of our patients, which was similar to earlier
findings.18 A review of available literature states a figure of
20-40%.5,6,9
Congestive cardiac failure occurred in 21% of our patients,
which is slightly lower than in some other studies.4-7 This
was nevertheless a predictor in the final model for in-
hospital mortality, similar to previous findings.13
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We found a higher proportion (51%) of patients with renal
failure in our study, while most series have reported
between 12-29%5,6,9,13 and recognised it as a poor
prognostic marker.11
Surgery was performed in one-fifth of our cohort, which is
slightly lower than in other series in which 12-27% had
received surgical intervention.4-6,13 European data7
revealed a surgical intervention rate of 52%. Surgical
intervention has been proven to confer a better prognosis
in many series13 and increased mortality in others19 but
was not significant in our model.
The mortality in our study is comparable to data from
developing countries who have reported in-hospital
mortality rates ranging from 19% to 31%. This data is
taken from series from India,5 Saudi Arabia,20 Tunisia21 and
Brazil.15
These figures are higher than previous data3,4,7 that
ranged from 12% to 19% with slightly higher six-month
mortality (22-27%).
Our study had several limitations. Firstly, the sample size
was small and thus factors which may be associated with
increased mortality may have failed to reach statistical
significance. Only in-patients admitted to a tertiary care
hospital were recruited and adverse outcomes as well as
complication rates were quite high as could be expected.
Therefore, these results may not be generalisable to the
whole population.
Since a significant number of patients had undergone
recent interventions, and the predominant isolated
micro-organism was staphylococcus aureus, the clinical
outcomes may reflect those of patients presenting with
acute endocarditis. Staphylococcus aureus endocarditis
itself is associated with worse outcomes. The
microbiology may also reflect that of patients with
nosocomial or acute endocarditis rather than community
acquired infection. 
Microbiological yield was lower than that in the West, but
the highest of all local studies published thus far. The
reasons for this have already been discussed.
Surgical intervention was performed in 20% of our
patients and was not found to be associated with
outcomes. This is in contrast to Western data where
surgical intervention confers better prognosis. However,
their intervention rates are much higher. The lower rates
of surgical intervention may have resulted in an erroneous
lack of association and may also reflect the poor medical
condition of patients who were deemed to be at
prohibitively high risk for surgery.
Conclusion
Over time the range of indications for in-dwelling central
venous catheters, pacemaker leads and prosthetic
material are expected to become more extensive. This
may lead to an increasing incidence of nosocomial and
procedure-related endocarditis. This necessitates the
development of validated models for predicting adverse
outcomes in patients with endocarditis. Significant
predictors of mortality in this study were the presence of
neurological complications (primarily cardio embolic
stroke), congestive cardiac failure, and arrhythmias.
Further studies are needed to devise prediction models
for both in-patients and out-patients with infective
endocarditis.
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